Terms: = Thyroid cancer AND SLC34A2, ENSG00000157765, O95436, NPTIIb, NAPI-IIb, NAPI-3B, FLJ90534, 10568 AND Prognosis
3 results:
1. Evaluation of the Prognostic Value of Solute Carrier Family 34 Member 2 "slc34a2" in Papillary thyroid Carcinoma: An Immunohistochemical Study.
Hakim SA; Abd El Atti RM; Faheim RM; Abou Gabal HH
Anal Cell Pathol (Amst); 2021; 2021():3198555. PubMed ID: 34336552
[TBL] [Abstract] [Full Text] [Related]
2. slc34a2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms.
He J; Zhou M; Li X; Gu S; Cao Y; Xing T; Chen W; Chu C; Gu F; Zhou J; Jin Y; Ma J; Ma D; Zou Q
Oncogene; 2020 Mar; 39(13):2658-2675. PubMed ID: 32005974
[TBL] [Abstract] [Full Text] [Related]
3. Solute carrier family 34 member 2 overexpression contributes to tumor growth and poor patient survival in colorectal cancer.
Liu L; Yang Y; Zhou X; Yan X; Wu Z
Biomed Pharmacother; 2018 Mar; 99():645-654. PubMed ID: 29653487
[TBL] [Abstract] [Full Text] [Related]
